The transcriptional regulator HSF1 has been reported to not only be critical to sustain cancer proliferation [98], but also up-regulate a subset of genes exclusively in patient-derived malignant cell specimens that are distinct from the canonical HSR targets. The gene discussed is HSF1; the disease is cancer.